| Literature DB >> 28042158 |
Rachel E Pollard1, Katherine D Watson1, Xiaowen Hu1, Elizabeth Ingham1, Katherine W Ferrara1.
Abstract
The purpose of this pilot study was to assess the feasibility of Cadence contrast pulse sequencing ultrasound to predict clinical and angiogenic tumor response in dogs undergoing chemotherapy. Contrast ultrasound facilitated visualization of bladder tumors but failed to identify a straightforward relationship between ultrasound measures and clinical outcome.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28042158 PMCID: PMC5157742
Source DB: PubMed Journal: Can Vet J ISSN: 0008-5286 Impact factor: 1.008